Research Overview
Research on vinegar (a fermented acetic acid solution) has most commonly focused on metabolic and cardiometabolic outcomes, with studies and reviews frequently examining effects on postprandial blood glucose regulation, markers of cardiovascular risk, and body weight/adiposity. The abstract provided also reflects an emerging extension of this literature into mental health, testing whether daily vinegar ingestion can influence depressive symptom burden and exploring potential biochemical mechanisms via metabolomics.
The strongest evidence base described in the abstract supports vinegar’s association with favorable metabolic outcomes (particularly glycemic management) and, to a lesser extent, risk factors relevant to heart disease and adiposity reduction. For depression-related outcomes, evidence is currently preliminary: in a 4-week randomized controlled trial in healthy overweight adults, vinegar providing 2.95 g/day acetic acid was associated with a statistically significant reduction in PHQ-9 scores versus a low-acetic-acid control, while the between-group difference for CES-D change was not significant. Mechanistically, metabolomics suggested increased nicotinamide and upregulation of the NAD+ salvage pathway in the vinegar group, which is biologically plausible given prior links between niacin/NAD+-related metabolism and mood, but remains correlational and not definitive proof of causality.
Key gaps include replication in larger and more diverse samples, longer follow-up to assess durability of effects, and trials in clinically diagnosed depressive disorders rather than generally healthy participants with self-reported symptoms. Additional research is also needed to clarify dose–response relationships (acetic acid amount and vinegar type), to disentangle vinegar-specific effects from broader dietary or expectancy effects, and to validate proposed mechanisms (e.g., NAD+/niacin pathway changes) with targeted biomarkers and mediation analyses. Safety, tolerability, and interactions with medications should be systematically evaluated, particularly if vinegar is considered as an adjunct intervention.
1. What conditions has Vinegar been studied for?
Depressive symptoms (self-reported symptom severity) in healthy overweight adults, assessed with the CES-D and PHQ-9 questionnaires over 4 weeks.
Metabolic/cardiometabolic outcomes are referenced as areas where vinegar has been linked to favorable outcomes, including:
Blood glucose management
Heart disease risk (risk markers, broadly stated)
Adiposity reduction (body fat/weight-related outcomes, broadly stated)
2. Does it work in treating those conditions? Summarize the evidence.
-
Depressive symptoms: One 4-week randomized controlled study compared daily ingestion of 2.95 g acetic acid (4 tablespoons vinegar) vs 0.025 g acetic acid (one vinegar pill) in healthy overweight adults.
PHQ-9: Mean scores fell 42% in the vinegar group vs 18% in controls; the between-group difference was statistically significant (p = 0.036).
CES-D: Mean scores fell 26% in the vinegar group vs 5% in controls; the between-group difference was reported as non-significant.
Interpretation: Evidence suggests vinegar ingestion may improve self-reported depressive symptomology over 4 weeks in this specific population, but results were mixed across scales (significant for PHQ-9, not for CES-D), and the study was in healthy overweight adults rather than patients with diagnosed depressive disorders.
-
Blood glucose, heart disease risk, adiposity: The abstract states vinegar is “linked to favorable outcomes” in these areas, but no specific trials, effect sizes, or statistical results are provided in the supplied text. Based on this abstract alone, efficacy for these outcomes cannot be quantified.
3. What health benefits does it have?
-
Potential mood-related benefit: In the described RCT, daily vinegar intake for 4 weeks was associated with a greater reduction in PHQ-9 depressive symptom scores than control.
-
Possible mechanistic benefit via niacin/NAD+ metabolism: Metabolomics showed:
Increased nicotinamide concentrations in vinegar participants
Upregulation of the NAD+ salvage pathway
These metabolic alterations were noted as being previously linked to improved mood, suggesting a plausible biological pathway, though this does not prove causality.
-
Other referenced benefits (not quantified in the provided abstract):
Favorable outcomes for blood glucose management
Potential improvement in heart disease risk markers
Potential adiposity reduction
4. Does it have any downsides or side effects?
The provided abstract does not report adverse events, side effects, or tolerability outcomes.
Evidence limitation: From the supplied text alone, no conclusions can be drawn about safety, side effects, or long-term risks.
Practical caution (not addressed in the abstract): Because the intervention involved ingesting 4 tablespoons of vinegar daily, tolerability (e.g., gastrointestinal irritation) would be an important consideration, but it is not evaluated or reported in the abstract provided.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
No pharmacogenomic analyses or genotype-stratified outcomes are described in the provided abstract.
No evidence provided that vinegar’s effects on depressive symptoms, nicotinamide levels, or NAD+ salvage pathway activity differ by genetic variation.
Research gap: While the study observed changes in niacin/NAD+ metabolism, it did not evaluate whether variants in related genes (e.g., NAD+ salvage pathway genes) modify response.
References
-
Daily Vinegar Ingestion Improves Depression and Enhances Niacin Metabolism in Overweight Adults: A Randomized Controlled Trial
Haley Barrong, Hannah Coven, Alexandra Lish, Samantha N Fessler, Paniz Jasbi (2024)
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!